Marker Therapeutics, Inc. — Director's Dealing 2016

Aug 12, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TAPIMMUNE INC (TPIV)
CIK: 0001094038
Period of Report: 2016-08-10

Reporting Person: Eastern Capital LTD (10% Owner)
Reporting Person: Portfolio Services Ltd. (10% Owner)
Reporting Person: DART KENNETH BRYAN (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-10	Common Stock	X	5000000	$0.5	Acquired	25000000	Direct
2016-08-10	Common Stock	J	3000000	—	Acquired	28000000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-08-10	Series C-1 Warrant	$0.5	X	5000000	Disposed	2020-03-09	Common Stock (5000000)	Direct
2016-08-10	Series F-1 Warrant	$0.6	J	5000000	Acquired		Common Stock (5000000)	Direct

Footnotes

F1: On August 10, 2016 Eastern Capital Limited exercised the remaining Issuer's Series C-1 Warrant at an exercise price of $0.50 per share and acquired an additional 5,000,000 shares of common stock.

F2: On August 10, 2016, simultaneously with the exercise of the remaining Series C-1 Warrant, Eastern Capital Limited acquired 3,000,000 shares of Common Stock and the Series F-1 Warrant to acquire 5,000,000 common shares which is exercisable upon the date of issuance with an exercise price of $0.60 per share and expires on the five year anniversary of the date of issuance. The additional shares and Series F-1 Warrant were issued in consideration of Eastern Capital Limited's agreement to amend certain outstanding warrants.